General MedicationsINJECTIONGeneric
CARBOPLATIN
CARBOPLATIN
Standard Dose
150MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CARBOPLATIN is listed in Drugs@FDA under application 091510 (ANDA).
Marketing status: Discontinued Active ingredient CARBOPLATIN Form and strength INJECTABLE;INJECTION - 150MG/VIAL Sponsor NATCO PHARMA USA Submission history Latest submission status date: 2012-05-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARBOPLATIN is listed in Drugs@FDA under application 091510 (ANDA). Marketing status: Discontinued Active ingredient CARBOPLATIN Form and strength INJECTABLE;INJECTION - 150MG/VIAL Sponsor NATCO PHARMA USA Submission history Latest submission status date: 2012-05-29 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.